THE CRITICAL PATH INSTITUTE

TUCSON, ARIZONA 857185893

$7.96M
Total Contract Value
27 awards
First Award
Aug 25, 2022
Last Award
Oct 30, 2025
Business Size
other than small
CAGE Code
35JZ0

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$4.24M14
541715$-18,014.418

Contract Awards

9 awards found

75F40119C10135
Department of Health and Human Services
$-18,014.41
Oct 30, 2025

THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2026
75F40124C00106
Department of Health and Human Services
$900K
Jul 15, 2025

BAA FOR DEVELOPMENT OF DRUG DEVELOPMENT TOOLS FOR ADTKD

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75F40124C00106
Department of Health and Human Services
$951K
Aug 16, 2024

BAA FOR DEVELOPMENT OF DRUG DEVELOPMENT TOOLS FOR ADTKD

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75F40122C00196
Department of Health and Human Services
$628K
May 21, 2024

BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75F40122C00196
Department of Health and Human Services
$724K
Sep 1, 2023

THE PURPOSE OF THIS MODIFICATION IS TO EXTENDING OPTION PERIOD OF PERFORMANCE END DATE FROM 01/28/2024 TO 05/28/2024.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75F40122C00196
Department of Health and Human Services
$95K
Apr 25, 2023

BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75F40119C10135
Department of Health and Human Services
$2.00M
Apr 20, 2023

BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75F40119C10135
Department of Health and Human Services
$-1,998,446.33
Mar 14, 2023

BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75F40122C00196
Department of Health and Human Services
$938K
Sep 26, 2022

BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI
KAEPADMRKHD3
CAGE Code
35JZ0
Address
1730 E RIVER RD STE 200
TUCSON, AZ 857185893
Congressional District
AZ-06

Parent Company

THE CRITICAL PATH INSTITUTE

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov